Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
by Karan Lal, DO, and Emilee Herringshaw, MD, MBA Dr
Rather than forcing the body into change, it works alongside it, making it a more approachable option for those looking for a steady, long-term strategy
We are transparent about who benefits from GLP-1 therapy and who may be better served by a different approach
None of the criminal cases has gone to trial yet
Direct medication costs (approximate, 2026): Brand-name Wegovy: $1,400 per month ($16,800 per year) Compounded semaglutide: $250 to $400 per month ($3,000 to $4,800 per year) With insurance coverage: $25 to $50 per month ($300 to $600 per year) Indirect costs of regain: Weight regain after discontinuation carries health costs that are harder to quantify but real: Increased risk of type 2 diabetes (if weight returns to pre-treatment level, diabetes risk returns to baseline) Increased cardiovascular risk (weight loss on GLP-1 agonists reduces cardiovascular events
